Skip to main content

Table 6 Stratification of clinical T stage of the detectable prostate cancers according to subgrouping of PSA level

From: Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases

PSA (ng/ml) No. of PC T1 T2 T3 T4
0–4 21 4 (19.0%) 11 (52.4%) 6 (28.6%) 0 (0.0%)
4–10 61 2 (3.3%) 18 (29.5%) 23 (37.7%) 18 (29.5%)
10–20 123 12 (9.8%) 25 (20.3%) 38 (30.9%) 48 (39.0%)
20–100 146 8 (5.5%) 36 (24.6%) 43 (29.5%) 59 (40.4%)
≥ 100 87 0 (0.0%) 7 (8.0%) 29 (33.3%) 51 (58.7%)
Total 438 26 (6.0%) 97 (22.1%) 139 (31.7%) 176 (40.2%)
  1. PSA prostate-specific antigen, PC prostate cancer